PerkinElmer Overview
Pro stress-test →PerkinElmer (PKI) is a global health technology company providing diagnostic instruments, reagents, and life sciences solutions to enable early disease detection and genomic research. The company serves pharmaceutical, biotechnology, academic, and healthcare institutions across diagnostics, life sciences, food, and applied markets.
Strategic Profile
Pro stress-test →PerkinElmer positions itself as a critical partner for precision diagnostics and genomic workflows, with diversified exposure spanning genetic disorder detection, infectious disease testing, and oncology research applications. The company emphasizes innovation in protein-coupled receptor and next-generation DNA sequencing technologies to support drug discovery and clinical diagnostics workflows.
Competitive Landscape
Pro stress-test →PerkinElmer competes in diagnostics and life sciences alongside Illumina (next-generation sequencing), Waters Corporation (analytical instruments), Agilent Technologies (laboratory solutions), and Quest Diagnostics (clinical diagnostics). The company differentiates through integrated diagnostic platforms combining reagents, instruments, and genomic sequencing capabilities for early disease detection and precision medicine applications.
Industry Context
PerkinElmer operates in Diagnostic laboratory instruments and genomic sequencing.
Key facts
Founded: 1940 · Headquarters: Waltham, US · Employees: 16,700 · Revenue: $2.8B–$3.1B (TTM) · Market cap: $11.0B–$14.5B